Patent · US Active

Nanoparticulate bisphosphonate compositions

US8158153B2 · kind B2 · utility

15Cited by

108References

12Claims

0Family size

Assignee

Alkermes Pharma Ireland Limited · IE

Inventors

Gary Liversidge · West Chester, US
Scott Jenkins · San Francisco, US

Key dates

Filing date	Mar 17, 2006
Grant date	Apr 17, 2012
Priority date	—
Expiry date	May 26, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P19/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Nanoparticulate bisphosphonate compositions, having an effective average particle size of less than 2000 nm, are described. The compositions are useful in treating bone resorption in a mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.